Many Seniors and Disabled Consumers Hit With Higher Prices for Prescription Drugs
Washington, DC–(ENEWSPF)–January 12, 2012. CVS Caremark Corporationwill pay $5 million to settle Federal Trade Commission charges that it misrepresented the prices of certain Medicare Part D prescription drugs – including drugs used to treat breast cancer symptoms and epilepsy – at CVS and Walgreens pharmacies. The allegedly deceptive claims caused many seniors and disabled consumers to pay significantly more for their drugs…
